Literature DB >> 3326653

Cancer of the pancreas. 50 years of surgery.

B Gudjonsson1.   

Abstract

The course of 196 patients with proven carcinoma of the pancreas seen at Yale New Haven Hospital from 1972 to 1982 was analyzed. Only 73% of the patients were preoperatively expected to have cancer of the pancreas. The patients who underwent resection had the longest mean survival but also the longest total hospital stay. Twenty-seven patients survived 1 year or more, but nonresected patients constituted 81.5% of this group. The only 5-year survivor did not undergo resection. Forty-seven percent of patients who survived 1 year and had not undergone gastroduodenal bypass, developed duodenal obstruction. It was not possible to identify a subset of patients with a favorable prognosis. A review totaling approximately 37000 patients, of whom 4100 had undergone resections, revealed only 156 survivors, 12 of whom had not been resected, for an overall survival rate of only 0.4%. No author had more than 3.4% of the total number of patients as 5-year survivors.

Entities:  

Mesh:

Year:  1987        PMID: 3326653     DOI: 10.1002/1097-0142(19871101)60:9<2284::aid-cncr2820600930>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  130 in total

1.  Metallic biliary stents for malignant obstructive jaundice:a review.

Authors:  Richard A Kozarek
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

Review 2.  Minimal-access approaches to complications of acute pancreatitis and benign neoplasms of the pancreas.

Authors:  T A Kellogg; K D Horvath
Journal:  Surg Endosc       Date:  2003-09-10       Impact factor: 4.584

3.  Diagnosing cancer of the pancreas.

Authors:  J N Thompson
Journal:  BMJ       Date:  1990-10-06

4.  Quantitative nuclear DNA content in fine needle aspirates of pancreatic cancer.

Authors:  A R Weger; K S Glaser; G Schwab; D Oefner; E Bodner; G U Auer; G Mikuz
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

5.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

6.  Risk factors for pancreatic cancer: case-control study.

Authors:  Manal M Hassan; Melissa L Bondy; Robert A Wolff; James L Abbruzzese; Jean-Nicolas Vauthey; Peter W Pisters; Douglas B Evans; Rabia Khan; Ta-Hsu Chou; Renato Lenzi; Li Jiao; Donghui Li
Journal:  Am J Gastroenterol       Date:  2007-08-31       Impact factor: 10.864

Review 7.  Proton therapy for pancreatic cancer.

Authors:  Romaine C Nichols; Soon Huh; Zuofeng Li; Michael Rutenberg
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

8.  Radioimmunolocalization of human pancreatic carcinoma xenograft by 99mTc-labeled YPC3 monoclonal antibody.

Authors:  Q Chen; S Yuan
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

9.  Is there a place for gastroenterostomy in patients with advanced cancer of the head of the pancreas?

Authors:  G P van der Schelling; R P van den Bosch; J H Klinkenbij; P G Mulder; J Jeekel
Journal:  World J Surg       Date:  1993 Jan-Feb       Impact factor: 3.352

10.  Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models.

Authors:  Kimberley S Samkoe; Alina Chen; Imran Rizvi; Julia A O'Hara; P Jack Hoopes; Stephen P Pereira; Tayyaba Hasan; Brian W Pogue
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.